From geopolitical disruption and climate risk to demand volatility and therapeutic complexity, today’s pharmaceutical supply chains are being stress-tested in ways few organizations were designed to handle. For large, global manufacturers, resilience is no longer a contingency plan, it is a core leadership mandate. Panelists will share how their organization is strengthening resilience across a complex, global network and moving beyond reactive risk management toward proactive preparedness. The conversation will explore how leaders are identifying vulnerabilities, building flexibility into operating models, and making deliberate trade-offs between efficiency, redundancy, and responsiveness to ensure continuity of supply and patient access. Rather than focusing on individual tools or initiatives, this session centers on the leadership decisions, governance models, and cultural shifts required to embed resilience into everyday operations—so organizations are better equipped not just to respond to disruption, but to absorb it and emerge stronger.

• Redefine resilience beyond risk mitigation to include adaptability, continuity, and long-term performance
• Identify where to build flexibility, buffers, and optionality across global supply networks
• Balance efficiency, cost, and resilience in an environment of persistent uncertainty
• Lead organizational and cultural shifts that make resilience a sustained capability, not a one-time response

As theft, tampering, counterfeiting, and cargo diversion surge across global trade lanes, freight security has become a critical pillar of pharma supply chain resilience. With high-value products, temperature-controlled shipments, and increasingly complex distribution networks, pharmaceutical companies face escalating threats and growing pressure to modernize their security strategies. In this candid, solutions-oriented discussion, senior supply chain leaders will explore how to protect high-value freight across every mile of transit. From mitigating organized cargo theft to improving visibility and chain-of-custody integrity, this panel will share practical approaches and emerging tools needed to safeguard product, brand, and patient trust.

• Implement real-time visibility and chain-of-custody tools to proactively detect and prevent shipment risks.
• Strengthen security protocols across carriers, 3PLs, and high-risk lanes through standardized SLAs and partner accountability.
• Mitigate emerging threats with risk-based freight security strategies aligned to product value, temperature requirements, and regulatory expectations.